Serving hundreds of leading biopharmaceutical companies globally:

Generated: December 18, 2018

DrugPatentWatch Database Preview

TECENTRIQ Drug Profile

« Back to Dashboard

Summary for Tradename: TECENTRIQ

Patents:	7
Applicants:	1
BLAs:	2
Suppliers: see list	1

Pharmacology for TECENTRIQ

Ingredient-type	Antibodies, Monoclonal, Humanized Antibodies, Monoclonal Antibodies
Mechanism of Action	Programmed Death Receptor-1-directed Antibody Interactions

US Patents for TECENTRIQ

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Genentech Inc	TECENTRIQ	atezolizumab	INJECTABLE; INJECTION	761041	001	2016-10-18	➤ Sign Up	Yeda Research and Development Co. Ltd. (Rehovot, IL)	➤ Sign Up	RX		search
Genentech Inc	TECENTRIQ	atezolizumab	INJECTABLE; INJECTION	761041	001	2016-10-18	➤ Sign Up	Yeda Research and Development Co. Ltd. (Rehovot, IL)	➤ Sign Up	RX		search
Genentech Inc	TECENTRIQ	atezolizumab	INJECTABLE; INJECTION	761041	001	2016-10-18	➤ Sign Up	Yeda Research and Development Co. Ltd. (Rehovot, IL)	➤ Sign Up	RX		search
Genentech Inc	TECENTRIQ	atezolizumab	INJECTABLE; INJECTION	761041	001	2016-10-18	➤ Sign Up	IBC Pharmaceuticals, Inc. (Morris Plains, NJ)	➤ Sign Up	RX		search
Genentech Inc	TECENTRIQ	atezolizumab	INJECTABLE; INJECTION	761041	001	2016-10-18	➤ Sign Up		➤ Sign Up	RX		search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

International Patents for TECENTRIQ

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2015126548	➤ Sign Up
Japan	6361039	➤ Sign Up
Canada	2874864	➤ Sign Up
Mexico	2016011832	➤ Sign Up
Australia	2017322656	➤ Sign Up
Country	Document Number	Estimated Expiration

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington

McKinsey

Harvard Business School

Dow

Express Scripts

QuintilesIMS

Boehringer Ingelheim

Healthtrust

Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.